Home> Products> potent immunosuppressive drug

{ "products": [ { "_id": "69d4ac713c63c5c22eae550a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Triamciolone tablets 4mg", "description": "Methidenosole 4 is a widely used prescription medication containing Triamcinolone Tablets IP 4mg, a potent corticosteroid designed to reduce inflammation and suppress immune responses. It is commonly prescribed by healthcare professionals to manage a variety of allergic, inflammatory, and autoimmune conditions. Due to its effectiveness and versatility, Methidenosole 4 has become a trusted option in modern medical treatment.\n\nIn this detailed guide, you will learn how Methidenosole 4 works, its uses, key benefits, potential side effects, and important precautions.\n\nHow Methidenosole 4 (Triamcinolone Tablets IP 4mg) Works\n\nTriamcinolone belongs to the class of drugs known as corticosteroids. It works by mimicking the action of natural hormones produced by the adrenal glands. These hormones play a vital role in controlling inflammation and immune system responses.\n\nMethidenosole 4 acts by:\n\nReducing the production of inflammatory chemicals in the body\nSuppressing overactive immune responses\nDecreasing swelling, redness, and itching\nPreventing allergic reactions from worsening\n\nThis mechanism makes it highly effective in treating conditions where inflammation or immune dysfunction is involved.\n\nUses of Methidenosole 4 (Triamcinolone 4mg Tablets)\n\nMethidenosole 4 is prescribed for a wide range of medical conditions, including:\n\n1. Allergic Disorders\nSevere allergies\nAllergic rhinitis (hay fever)\nDrug or food allergies\nSkin allergies\n2. Skin Conditions\nEczema\nPsoriasis\nDermatitis\nRashes and itching\n3. Respiratory Conditions\nAsthma\nChronic obstructive pulmonary disease (COPD)\nBronchitis-related inflammation\n4. Autoimmune Diseases\nRheumatoid arthritis\nLupus\nInflammatory bowel disease\n5. Eye and Ear Inflammation\nUveitis\nConjunctivitis (non-infectious)\n6. Other Conditions\nHormonal disorders\nCertain types of cancer (as supportive therapy)\nPost-surgical inflammation\n\nDue to its strong anti-inflammatory properties, Methidenosole 4 is often prescribed when other medications are not sufficiently effective.\n\nKey Benefits of Methidenosole 4\n1. Powerful Anti-Inflammatory Action\n\nMethidenosole 4 quickly reduces swelling, redness, and pain, providing fast relief in inflammatory conditions.\n\n2. Effective Allergy Control\n\nIt helps manage severe allergic reactions that do not respond to standard antihistamines.\n\n3. Versatile Treatment Option\n\nThis medication is used across multiple medical fields, including dermatology, pulmonology, and rheumatology.\n\n4. Improved Quality of Life\n\nBy controlling chronic symptoms like pain, itching, and breathing difficulty, it significantly enhances daily comfort.\n\n5. Long-Lasting Relief\n\nCompared to some other corticosteroids, Triamcinolone provides sustained action, reducing the need for frequent dosing.\n\nDosage and Administration\nMethidenosole 4 should be taken strictly as prescribed by a healthcare professional.\nIt is usually taken orally with water, with or without food.\nDosage depends on the condition, severity, and patient response.\nDo not abruptly stop the medication without consulting a doctor, as it may cause withdrawal symptoms.\nCommon Side Effects of Methidenosole 4\n\nLike all medications, Methidenosole 4 may cause some side effects. Common ones include:\n\nIncreased appetite\nWeight gain\nMood changes (irritability, anxiety)\nIndigestion or stomach discomfort\nDifficulty sleeping\nMild swelling (fluid retention)\n\nThese side effects are usually temporary and may reduce as the body adjusts to the medication.\n\nSerious Side Effects (Seek Medical Attention)\n\nAlthough rare, some serious side effects may occur:\n\nHigh blood pressure\nSevere mood swings or depression\nVision problems\nIncreased risk of infections\nElevated blood sugar levels\nBone thinning (osteoporosis) with long-term use\n\nIf you experience any unusual or severe symptoms, contact your healthcare provider immediately.\n\nPrecautions and Warnings\n\nBefore using Methidenosole 4, consider the following:\n\nInform your doctor if you have diabetes, hypertension, or any infections\nAvoid exposure to contagious diseases like chickenpox or measles\nLong-term use should be monitored regularly\nNot recommended during pregnancy or breastfeeding without medical advice\nAvoid alcohol consumption to reduce the risk of stomach irritation\nDrug Interactions\n\nMethidenosole 4 may interact with other medications such as\n\nAntidiabetic drugs\nBlood pressure medications\nAnticoagulants\nNon-steroidal anti-inflammatory drugs (NSAIDs)\n\nAlways inform your doctor about all medicines and supplements you are taking.\n\nStorage Instructions\nStore in a cool, dry place away from direct sunlight\nKeep out of reach of children\nDo not use expired medication\nConclusion\n\nMethidenosole 4 (Triamcinolone Tablets IP 4 mg) is a highly effective corticosteroid medication widely used for managing inflammation, allergies, and autoimmune conditions. Its powerful anti-inflammatory and immunosuppressive properties make it a reliable choice for treating various chronic and acute conditions.", "price": 64.0, "discountamount": 19.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2368, "imageuri": "https://productimages.withfloats.com/actual/69d4ac740f378e14f1e7b1b2.png", "tileimageuri": "https://productimages.withfloats.com/tile/69d4ac740f378e14f1e7b1b2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-04-07T07:04:17.247Z", "updatedon": "2026-04-07T07:29:50.371Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/triamciolone-tablets-4mg/2368", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Methidenosole 4", "category": "GENERAL RANGE", "tags": [ "triamcinolone tablets 4 mg", "triamcinolone tablets 4 mg dosage", "triamcinolone tablets 4mg uses", "triamcinolone tablets 4mg side effects", "triamcinolone tablets ip 4mg india", "buy triamcinolone tablets 4mg online", "triamcinolone tablets 4mg price in india", "triamcinolone tablets 4mg bulk purchase", "Methidenosole 4 price in india", "Methidenosole 4 triamcinolone tablets", "Methidenosole 4 supplier india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69cbc41faf13b43636b170d0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Everolimus Tablets 0.5 mg", "description": "EVERENOLIMUS 0.5 is a prescription medication containing Everolimus 0.5 mg tablets, a potent mTOR (mammalian target of rapamycin) inhibitor used in advanced medical treatments. This medicine works by regulating cell growth, division, and immune system activity, making it effective in both oncology and transplant care.\nEverolimus has become a crucial therapeutic option for patients requiring targeted cancer therapy or immunosuppression after organ transplantation. Its dual functionality—controlling abnormal cell proliferation and preventing organ rejection—makes it a preferred choice among healthcare providers.\nIn India, EVERENOLIMUS 0.5 is increasingly prescribed for specific cancers, post-transplant care, and rare disorders like tuberous sclerosis complex. Its oral tablet form allows convenient administration while maintaining effective systemic action.\n\nUses of EVERENOLIMUS 0.5\n\nEVERENOLIMUS 0.5 is indicated for a range of serious medical conditions:\n1. Organ Transplantation\nHelps prevent rejection of kidney and liver transplants\nMaintains graft survival by suppressing the immune response\n2. Cancer Treatment\nHormone receptor-positive, HER2-negative advanced breast cancer\nAdvanced kidney cancer (renal cell carcinoma)\nNeuroendocrine tumors (pancreas, lungs, gastrointestinal tract)\n3. Tuberous Sclerosis Complex (TSC)\nManages non-cancerous tumors such as subependymal giant cell astrocytoma (SEGA)\nReduces tumor growth in vital organs\n4. Other Rare Conditions\nCertain types of cardiac or renal vascular growth disorders, under specialist supervision\nBenefits of EVERENOLIMUS 0.5\n1. Dual Therapeutic Action\nOffers immunosuppressive benefits for transplant patients\nProvides targeted anti-cancer activity to control abnormal cell growth\n2. Improved Transplant Outcomes\nReduces the risk of graft rejection\nEnsures long-term functionality of transplanted organs\n3. Targeted Cancer Therapy\nFocuses on specific cellular pathways\nMinimizes damage to healthy cells compared to conventional chemotherapy\n4. Slows Disease Progression\nEffective in advanced cancers and benign tumors\nControls disease symptoms and improves patient quality of life\n5. Convenient Oral Formulation\nEasy to take as a tablet without injections\nEnables consistent and controlled drug delivery\n6. Enhances Long-Term Management\nRegular use supports chronic disease control\nReduces hospitalization and complication rates\nDosage of EVERENOLIMUS 0.5\n\nThe exact dosage depends on the patient’s condition, weight, and response to therapy. It must be determined by a healthcare professional.\n\nGeneral Guidelines:\nTypically taken once daily\nSwallow the tablet whole with water\nCan be taken with or without food, but maintain consistency\nMonitoring Requirements:\nRegular blood tests to check kidney and liver function\nMonitoring drug levels ensures effectiveness and safety\nMissed Dose:\nTake the missed dose as soon as possible\nIf it is near the next scheduled dose, skip the missed dose\nDo not double the dose\n\nSide Effects of EVERENOLIMUS 0.5\n\nEVERENOLIMUS 0.5 may cause side effects, which can range from mild to serious.\nCommon Side Effects:\nFatigue and weakness\nNausea or vomiting\nMouth ulcers\nDiarrhea\nLess Common Side Effects:\nEdema (swelling in hands or feet)\nIncreased blood sugar and cholesterol levels\nSkin rash\nSerious Side Effects:\nIncreased risk of infections due to suppressed immunity\nLung inflammation (non-infectious pneumonitis)\nImpaired kidney or liver function\nDelayed wound healing\nWhen to Seek Medical Attention:\nPersistent fever or signs of infection\nShortness of breath or chest pain\nSevere weakness, dizziness, or swelling\nUnusual bleeding or bruising\nPrecautions and Warning\n1. Infection Risk\nSuppressed immunity increases susceptibility to infections\nAvoid exposure to people with contagious diseases\n2. Liver and Kidney Function\nRegular tests are necessary to monitor organ health\n3. Vaccinations\nAvoid live vaccines during treatment\nConsult your doctor before any vaccination\n4. Drug Interactions\nInform your doctor about all medications, including antibiotics, antifungals, and supplements\n5. Pregnancy and Contraception\nNot recommended during pregnancy\nEffective contraception is advised during and after treatment\n6. Surgery and Wound Healing\nInform your doctor before undergoing surgery\nWound healing may be delayed due to Everolimus effects\n7. Sun Protection\nIncreased sensitivity to sunlight\nUse sunscreen and protective clothing\n\nConclusion\n\nEVERENOLIMUS 0.5 (Everolimus Tablets 0.5 mg) is a highly effective oral medication that offers dual benefits for cancer patients and organ transplant recipients. Its targeted mechanism ensures precise therapeutic action while minimizing unnecessary side effects.\nBy preventing organ rejection, controlling tumor growth, and improving long-term outcomes, EVERENOLIMUS 0.5 has become a trusted choice in modern clinical practice. Patients in India seeking reliable, medically supervised care for complex conditions can benefit greatly from this advanced therapy.\nStrict adherence to dosage, regular monitoring, and medical supervision are essential for safe and effective use. Combined with lifestyle and dietary guidance, EVERENOLIMUS 0.5 supports improved quality of life and enhanced clinical outcomes.", "price": 643.0, "discountamount": 193.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2359, "imageuri": "https://productimages.withfloats.com/actual/69cbc421595f848aedb0807c.png", "tileimageuri": "https://productimages.withfloats.com/tile/69cbc421595f848aedb0807c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-03-31T12:54:55.448Z", "updatedon": "2026-04-01T12:52:30.718Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/everolimus-tablets-0-5-mg/2359", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "EVERENOLIMUS 0.5", "category": "Oncology", "tags": [ "everolimus tablets 0.5 mg uses", "everolimus 0.5 mg dosage and benefits", "everolimus 0.5 mg side effects and precautions", "everolimus 0.5 mg mechanism of action", "everolimus 0.5 mg tablet guide", "everolimus 0.5 mg price in India", "everolimus tablets bulk supplier", "best everolimus tablets 0.5 mg price and uses India", "buy everolimus 0.5 mg tablets online at best price", "everolimus tablets for organ transplant patients India" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6937c92e461b07808ef722e4", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "tab cyclosporine 100mg", "description": "Cyclosporine, marketed under the brand name CYCLOPURE 100, is a potent immunosuppressant medication widely used in clinical settings to prevent organ transplant rejection and to manage various autoimmune disorders. Available as a 100mg oral capsule, CYCLOPURE 100 plays a critical role in modulating the immune system, helping patients maintain graft survival and control symptoms of immune-related diseases.\n\nProduct Description\nCYCLOPURE 100 contains cyclosporine, a cyclic polypeptide consisting of 11 amino acids, derived from the fungus Tolypocladium inflatum. It selectively inhibits the activity of T-lymphocytes, a subset of white blood cells that play a central role in immune response. By targeting these immune cells, cyclosporine helps prevent the body’s immune system from attacking transplanted organs, such as kidneys, liver, or heart, and reduces inflammation in autoimmune diseases.\n\nThe capsules are formulated for oral administration, with each capsule containing 100mg of cyclosporine. This dosage provides an effective balance between immunosuppression and safety for most adult patients, although dosing must be carefully tailored by healthcare providers based on patient response, therapeutic drug monitoring, and condition severity.\n\nUses of CYCLOPURE 100\nCYCLOPURE 100 is primarily indicated for the following medical purposes:\n\nPrevention of Organ Transplant Rejection: It is commonly prescribed to recipients of kidney, liver, heart, or other organ transplants to prevent acute and chronic rejection by suppressing immune responses that target the graft.\nAutoimmune Disease Management: Cyclosporine is effective in treating autoimmune disorders such as rheumatoid arthritis, psoriasis, and certain types of nephrotic syndrome. By reducing immune system overactivity, it helps alleviate symptoms such as joint inflammation, skin lesions, and kidney damage.\n\nSevere Atopic Dermatitis: In cases where conventional treatments are ineffective, cyclosporine may be used to control symptoms of severe eczema by modulating immune hyperreactivity.\n\nOther Off-Label Uses: Occasionally, cyclosporine is used for other immune-mediated conditions like uveitis, Crohn’s disease, and some forms of lupus nephritis depending on physician discretion.\n\nKey Benefits\nEffective Immunosuppression: CYCLOPURE 100 is known for its potent ability to suppress immune responses selectively, significantly reducing the risk of organ rejection after transplantation and improving graft survival rates.\n\nVersatility in Autoimmune Conditions: Beyond organ transplantation, cyclosporine’s immunomodulatory effects provide relief in autoimmune diseases by controlling inflammation and immune overactivity that cause tissue damage.\n\nImprovement in Quality of Life: By controlling disease symptoms such as joint pain, skin inflammation, or kidney impairment, CYCLOPURE 100 enables patients to experience improved physical comfort and daily functioning.\n\nOral Administration Convenience: The capsule form ensures ease of use and better patient compliance compared to injectable immunosuppressants, allowing therapy to be managed on an outpatient basis.\n\nTherapeutic Drug Monitoring: The availability of blood level monitoring helps customize dosage and maximize therapeutic effects while minimizing toxicity.\n\nSide Effects and Precautions\nWhile CYCLOPURE 100 is highly beneficial, it carries a risk of side effects due to its immunosuppressive nature and systemic effects. Common, less severe side effects include:\n\nGingival hyperplasia (gum overgrowth)\n\nTremors or mild neurological symptoms\n\nHypertension (high blood pressure)\n\nIncreased hair growth (hypertrichosis)\n\nGastrointestinal disturbances (nausea, diarrhea)\n\nMore serious adverse effects, which require immediate medical attention, can include:\n\nNephrotoxicity: Cyclosporine can affect kidney function; regular monitoring of kidney function tests is essential.\n\nIncreased Risk of Infections: Suppression of the immune system increases vulnerability to bacterial, viral, and fungal infections.\n\nHepatotoxicity: Liver function should be monitored, as cyclosporine may cause elevated liver enzymes or more severe liver damage.\n\nMalignancies: Long-term use has been associated with an increased risk of certain cancers, particularly lymphomas and skin cancers.\n\nElectrolyte Imbalances: Hypomagnesemia and hyperkalemia are possible and require monitoring.\n\nPatients must inform their healthcare providers about other medications they take, as cyclosporine has significant drug interactions that can affect its blood levels and toxicity risk, including with antibiotics, antifungals, anticonvulsants, and others.\n\nConclusion\nCYCLOPURE 100 (Cyclosporine 100mg) stands as a cornerstone immunosuppressant medication that plays a vital role in preventing organ rejection and managing autoimmune diseases. Its targeted immunosuppressive action effectively reduces disease burden, enhances graft survival, and improves patients’ quality of life. Although it entails risks of side effects, careful medical supervision, therapeutic drug monitoring, and adherence to prescribed dosing protocols effectively mitigate these concerns.\n\nFor patients undergoing organ transplantation or those with autoimmune conditions unresponsive to standard therapies, CYCLOPURE 100 provides a valuable therapeutic solution. Always consult a healthcare professional before starting or adjusting therapy with CYCLOPURE 100 to ensure the safest and most effective use tailored to individual clinical needs.", "price": 1014.0, "discountamount": 305.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2239, "imageuri": "https://productimages.withfloats.com/actual/6937c930ed26b2c06ce34f7e.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/6937c930ed26b2c06ce34f7e.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-09T07:01:02.399Z", "updatedon": "2026-03-30T07:51:22.499Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tab-cyclosporine-100mg/2239", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CYCLOPURE 100", "category": "NEUROLOGY RANGE", "tags": [ "Cyclosporine", "fungus", "white blood cells.", "Prevention of Organ Transplant Rejection.", "Autoimmune Disease Management.", "tab cyclosporine 100mg.", "cap cyclosporine 100mg.", "cyclosporine 100mg price.", "cyclosporine 100mg tablet.", "cap cyclosporine 100mg uses in hindi.", "cost of cyclosporine 100mg.", "cyclosporine 100mg tablet price." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66d6df52731125bdd4e1003b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VALGANCICLOVIR TABLET 450 MG", "description": "VOLANE SOURCE 450 is a pharmaceutical tablet containing Valganciclovir at a dosage strength of 450 mg. It is a potent antiviral medication primarily designed to treat and prevent certain viral infections caused by cytomegalovirus (CMV), especially in immunocompromised patients such as those undergoing organ transplants or living with HIV/AIDS. Manufactured adhering to strict quality standards under the tablet IP (Indian Pharmacopoeia), VOLANE SOURCE 450 ensures consistent efficacy and safety for patients requiring antiviral therapy.\n\nComposition and Pharmacological Profile\nEach film-coated tablet of VOLANE SOURCE 450 contains 450 mg of Valganciclovir as the active ingredient. Valganciclovir is a prodrug of ganciclovir, meaning it is converted in the body into ganciclovir, which is the active antiviral agent. Its mechanism involves inhibiting viral DNA synthesis by competing with deoxyguanosine triphosphate for incorporation into viral DNA, thereby suppressing the replication of CMV and related herpes viruses.\n\nPrimary Uses of VOLANE SOURCE 450\nTreatment of CMV Retinitis: CMV retinitis is a serious viral eye infection common in patients with weakened immune systems, such as AIDS patients. It leads to inflammation and possible vision loss if left untreated. VOLANE SOURCE 450 is a frontline therapy used to halt the progression of this infection.\n\nPrevention of CMV Disease in Transplant Patients: Solid organ transplant recipients and bone marrow transplant patients are at high risk of CMV infection due to immunosuppressive drugs. Prophylactic use of VOLANE SOURCE 450 helps in preventing CMV disease in these vulnerable groups.\n\nTreatment of CMV Infection: Apart from retinitis, CMV can cause systemic infections affecting multiple organs, including lungs, digestive tract, and nervous system. VOLANE SOURCE 450 is used for managing such infections effectively.\n\nPart of Combination Therapy: It may also be prescribed alongside other antiviral agents as part of combination treatment protocols tailored to complex viral infections, enhancing viral suppression.\n\nKey Benefits of Using VOLANE SOURCE 450\nHigh Oral Bioavailability: Being a prodrug, Valganciclovir is well absorbed orally and converted efficiently to ganciclovir in the body, enabling effective antiviral levels.\n\nWide Spectrum of Action: Targets multiple herpesviruses with high specificity, primarily cytomegalovirus, reducing viral load and infection severity.\n\nReduced Risk of CMV Disease Post-Transplant: By preventing CMV infection in transplant recipients, VOLANE SOURCE 450 significantly lowers the risk of post-transplant complications related to viral disease.\n\nConvenient Oral Dosage: Unlike intravenous ganciclovir, VOLANE SOURCE 450 allows for easier home administration, improving patient compliance and quality of life.\n\nEffective Against Resistant Strains: Used in recurrent and resistant CMV infections, especially where other therapies fail.\n\nProtects Vision: In CMV retinitis patients, prompt use of VOLANE SOURCE 450 can preserve vision and prevent blindness due to viral damage.\n\nRecommended Dosage and Administration\nThe dosing of VOLANE SOURCE 450 depends on the condition being treated, kidney function, and patient immune status. It is typically prescribed by healthcare professionals following careful medical assessment.\n\nFor CMV retinitis treatment, the initial dose is usually higher and then tapered down for maintenance.\n\nFor CMV prophylaxis post-transplant, a standard dose is taken once or twice daily for several months.\n\nIt is advised to swallow tablets whole with food to enhance absorption.\n\nRegular monitoring of blood counts and kidney function is essential during therapy since the drug can impact bone marrow and renal function.\n\nPotential Side Effects of VOLANE SOURCE 450\nLike any potent antiviral medication, VOLANE SOURCE 450 can cause side effects. Awareness and timely reporting to a healthcare provider are important to manage these effects safely.\n\nCommon side effects include:\n\nGastrointestinal symptoms: Nausea, vomiting, diarrhea, and abdominal pain.\n\nBone marrow suppression: Leading to anemia, neutropenia (low neutrophils), or thrombocytopenia (low platelets), which increase infection risks and bruising.\n\nHeadache and fatigue: Mild to moderate headache and tiredness may occur.\n\nFever and infections: Due to immune suppression, secondary infections may arise.\n\nElectrolyte imbalance: Occasionally, abnormalities in blood calcium or potassium levels.\n\nRare hypersensitivity reactions: Skin rash, itching, or swelling which require immediate medical attention.\n\nPrecautions and Contraindications\nPatients with severe renal impairment require dose adjustments or alternative therapies to avoid toxicity.\n\nPregnant or breastfeeding women should avoid this drug due to potential harm to the fetus or infant.\n\nRegular blood tests are necessary to monitor for hematologic or renal side effects.\n\nUse caution in patients with pre-existing neutropenia or anemia.\n\nConclusion\nVOLANE SOURCE 450 (Valganciclovir Tablet IP 450 mg) represents a reliable and efficacious antiviral therapy specifically targeting cytomegalovirus infections. Its role in treatment and prevention of CMV-related diseases, especially among immunocompromised patients, makes it invaluable in clinical practice.\n\nIts oral formulation allows for easy administration and effective drug delivery, improving patient adherence and outcomes. While the risk of side effects exists, careful monitoring and adherence to prescribed dosages minimize complications.\n\nOverall, VOLANE SOURCE 450 offers a potent solution against serious viral infections, helping preserve health, prevent complications, and improve quality of life for vulnerable patient populations.\n\n", "price": 3944.0, "discountamount": 2367.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "viral DNA", "rare cases", "Key Benefits", "CMV Retinitis", "VOLANE SOURCE", "CMV infection", "various organs", "kidney function", "prescribed course", "chain termination", "active ingredient", "organ transplants", "medical condition", "blood cell counts", "healthcare provider", "severe side effects", "Common Side Effects", "Regular blood tests", "complete eradication", "antiviral medication", "high bioavailability", "severe eye infection", "Serious Side Effects", "high-risk individuals", "convenient oral option", "bone marrow suppression", "weakened immune systems", "VALGANCICLOVIR TABLET IP", "High Oral Bioavailability", "Immediate medical attention" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1950, "imageuri": "https://productimages.withfloats.com/actual/6936b55236477d52c1e94700.png", "tileimageuri": "https://productimages.withfloats.com/tile/6936b55236477d52c1e94700.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-09-03T10:05:06.943Z", "updatedon": "2026-03-12T06:40:40.942Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/valganciclovir-tablet-450-mg/1950", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VOLANE SOURCE 450", "category": "CARDIOLOGYRANGE", "tags": [ "VALGANCICLOVIR TABLET IP 450 MG USUE", "Valganciclovir Tablet IP 450 mg", "infections caused by cytomegalovirus (CMV).", "VOLANE SOURCE 450", "helps control the spread of the CMV infection within the body", "high bioavailability", "improve quality of life for vulnerable patient populations", "valganciclovir tablet 450 mg uses", "valganciclovir 450 mg tablet price in India", "valganciclovir 450 mg dosage information", "valganciclovir tablet 450 mg composition", "valganciclovir 450 mg tablet side effects", "valganciclovir 450 mg tablet benefits", "what is valganciclovir tablet 450 mg used for", "how valganciclovir 450 mg works", "valganciclovir 450 mg tablet mechanism of action", "valganciclovir tablet 450 mg storage instructions", "valganciclovir 450 mg tablet administration guide", "buy valganciclovir 450 mg tablet online", "valganciclovir 450 mg tablet supplier India", "valganciclovir tablet 450 mg wholesale price", "valganciclovir 450 mg tablet manufacturer", "valganciclovir 450 mg tablet distributor", "valganciclovir 450 mg generic tablet", "valganciclovir 450 mg tablet substitute", "valganciclovir 450 mg antiviral tablet", "when to take valganciclovir 450 mg tablet" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6667e2f2c6406f17e8a39858", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Tamsulosin Hydrochloride 0.4 mg PR & Deflazacort 30 mg", "description": "TASMULINE DFZ\nTamsulosin Hydrochloride 0.4 mg PR & Deflazacort 30 mg\nThe combination of Tamsulosin Hydrochloride 0.4 mg PR and Deflazacort 30 mg is a well-designed therapeutic formulation used primarily in the management of urinary tract disorders, especially conditions associated with inflammation, swelling, and obstruction of urine flow. This dual-action medicine is commonly prescribed in cases such as benign prostatic hyperplasia (BPH), ureteric stones, and post-urological inflammatory conditions, where both muscle relaxation and anti-inflammatory action are required for effective symptom relief.\n\nBy combining an alpha-1 adrenergic blocker (Tamsulosin) with a corticosteroid (Deflazacort), this formulation addresses both the mechanical obstruction and the inflammatory component, offering faster relief and improved patient comfort.\n\nProduct Description\nTamsulosin Hydrochloride 0.4 mg PR\n\nTamsulosin Hydrochloride is a selective alpha-1A adrenergic receptor blocker. It works by relaxing the smooth muscles of the prostate gland, bladder neck, and urethra, thereby improving urine flow and reducing symptoms such as difficulty in urination, weak stream, incomplete bladder emptying, and frequent urination.\n\nThe PR (Prolonged Release) formulation ensures:\n\nControlled and sustained release of the drug\n\nConsistent blood levels throughout the day\n\nReduced risk of sudden blood pressure drops\n\nImproved patient compliance with once-daily dosing\n\nDeflazacort 30 mg\n\nDeflazacort is a synthetic glucocorticoid with potent anti-inflammatory and immunosuppressive properties. Compared to many other steroids, Deflazacort is known for:\n\nLower impact on bone density\n\nReduced fluid retention\n\nBetter safety profile when used under medical supervision\n\nIn urological conditions, Deflazacort helps by:\n\nReducing inflammation and swelling around the urinary tract\n\nDecreasing pain and irritation\n\nSupporting faster recovery\n\nUses of Tamsulosin Hydrochloride 0.4 mg PR & Deflazacort 30 mg\n\nThis combination is prescribed in various urological and inflammatory conditions, including:\n\n1. Benign Prostatic Hyperplasia (BPH)\n\nEnlargement of the prostate gland can obstruct urine flow and cause discomfort. Tamsulosin relaxes the prostate muscles, while Deflazacort reduces associated inflammation, providing effective symptom relief.\n\n2. Ureteric and Renal Stones\n\nIn patients with urinary stones, this combination helps:\n\nRelax ureteral smooth muscles\n\nReduce inflammation around the stone\n\nFacilitate easier and less painful stone passage\n\n3. Post-operative Urological Inflammation\n\nAfter urological surgeries or procedures, inflammation may cause pain and urinary difficulty. Deflazacort controls inflammation, while Tamsulosin supports smooth urination.\n\n4. Urinary Tract Obstruction with Inflammation\n\nConditions involving swelling or irritation of the urinary tract benefit from the dual mechanism of muscle relaxation and inflammation control.\n\nKey Benefits of the Combination\nDual Mechanism for Better Outcomes\n\nTamsulosin improves urine flow by relaxing smooth muscles\n\nDeflazacort reduces swelling, pain, and inflammation\n\nFaster Symptom Relief\n\nPatients often experience quicker improvement in urinary symptoms compared to single-drug therapy.\n\nImproved Patient Comfort\n\nReduction in pain, burning sensation, urinary urgency, and nocturia improves overall quality of life.\n\nProlonged Release Advantage\n\nThe PR formulation of Tamsulosin ensures steady drug action throughout the day with fewer side effects.\n\nBetter Tolerability\n\nDeflazacort offers steroid benefits with comparatively fewer long-term adverse effects when used appropriately.\n\nDosage and Administration\n\nThe medicine is usually taken once daily, preferably after the same meal each day\n\nTablets/capsules should be swallowed whole and not crushed or chewed\n\nDosage duration depends on the severity of the condition and should always be as advised by a physician\n\nImportant: This medicine should only be used under medical supervision, especially due to the presence of a corticosteroid.\n\nPossible Side Effects\n\nLike all medicines, Tamsulosin Hydrochloride 0.4 mg PR & Deflazacort 30 mg may cause side effects in some patients.\n\nCommon Side Effects\n\nDizziness or light-headedness\n\nHeadache\n\nFatigue\n\nNasal congestion\n\nMild stomach upset\n\nIncreased appetite (due to Deflazacort)\n\nLess Common Side Effects\n\nLow blood pressure, especially on standing\n\nSleep disturbances\n\nMood changes\n\nIndigestion or heartburn\n\nRare but Serious Side Effects\n\nSevere allergic reactions\n\nVision disturbances\n\nSigns of infection (with prolonged steroid use)\n\nSudden swelling of face or throat\n\nPatients should immediately consult a doctor if any severe or unusual symptoms occur.\n\nPrecautions and Warnings\n\nUse cautiously in patients with low blood pressure\n\nNot recommended for patients with severe liver impairment unless advised\n\nLong-term use of Deflazacort requires monitoring for blood sugar, bone health, and infection risk\n\nPatients should not abruptly stop the medicine without medical advice\n\nInform the doctor about any ongoing medications to avoid drug interactions\n\nStorage Instructions\n\nStore in a cool, dry place\n\nProtect from direct sunlight and moisture\n\nKeep out of reach of children\n\nConclusion\nTamsulosin Hydrochloride 0.4 mg PR & Deflazacort 30 mg is a scientifically balanced combination that offers effective relief from urinary obstruction and inflammation-related symptoms. By targeting both muscle tension and inflammatory swelling, it provides comprehensive management for conditions like benign prostatic hyperplasia, urinary stones, and post-urological inflammation", "price": 580.0, "discountamount": 174.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Call", "4 mg", "Email", "Order", "doctor", "muscles", "bladder", "WhatsApp", "medication", "weak stream", "information", "combination", "Deflazacort", "sterispharma", "instructions", "inflammation", "sterisonline", "TASMULINE DFZ", "immune system", "corticosteroid", "optimal results", "urinary symptoms", "enlarged prostate", "frequent urination", "prostate enlargement", "difficulty urinating", "Tamsulosin Hydrochloride", "benign prostatic hyperplasia" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1700, "imageuri": "https://productimages.withfloats.com/actual/667d37fac303c6d6ad1375c5.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d37fac303c6d6ad1375c5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-11T05:38:58.084Z", "updatedon": "2026-03-17T06:23:04.276Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tamsulosin-hydrochloride-0-4-mg-pr-deflazacort-30-mg/1700", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TASMULINE DFZ", "category": "UROLOGYRANGE", "tags": [ "TASMULINE DFZ", "Tamsulosin Hydrochloride 0.4 mg PR", "Deflazacort 30 mg dosage", "Deflazacort 30 mg", "Deflazacort 30 mg", "Deflazacort 30 mg", "Tamsulosin Hydrochloride 0.4 mg PR and Deflazacort 30 mg", "urinary tract disorders.", "Benign Prostatic Hyperplasia (BPH)", "Urinary Tract Obstruction with Inflammation" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6662abb166170d1ff8cb4bbc", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TACRENOLIME 0.25", "description": "TACRENOLIME 0.25\nTacrolimus (0.25mg)\nTacrenolime 0.25 is a medication containing Tacrolimus at a strength of 0.25mg per dose. Tacrolimus is a potent immunosuppressive drug used primarily in transplant medicine to prevent rejection of transplanted organs like kidneys, liver, and heart.\n\nKey Features of TACRENOLIME 0.25:\n\nImmunosuppression: Tacrolimus works by inhibiting the activity of T-lymphocytes, a type of white blood cell involved in the immune response. This helps in preventing the body from attacking and rejecting transplanted organs.\n\nDosage: The recommended dosage of Tacrenolime 0.25 varies based on the patient's medical condition, transplant type, and response to treatment. It is crucial to follow the prescribed dosage regimen as directed by the healthcare provider.\n\nAdministration: Tacrenolime 0.25 is usually administered orally in the form of capsules or tablets. It is important to take the medication at the same time each day for optimal effectiveness.\n\nMonitoring: Patients taking Tacrenolime 0.25 require regular monitoring of their blood levels to ensure that the drug is within the therapeutic range and to minimize the risk of side effects.\n\nSide Effects: Common side effects of Tacrenolime 0.25 may include nausea, vomiting, diarrhea, headache, and changes in blood pressure. Serious side effects such as kidney problems or infections may also occur, requiring immediate medical attention.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \n\nhttps://www.sterisonline.com/product/tacrenolime-0-25-133684", "price": 129.0, "discountamount": 39.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "0.", "Call", "risk", "form", "body", "dose", "Order", "Email", "heart", "liver", "nausea", "changes", "tablets", "patient", "kidneys", "capsules", "WhatsApp", "activity", "vomiting", "diarrhea", "headache", "strength", "treatment", "same time", "rejection", "Tacrolimus", "infections", "medication", "TACRENOLIME", "sterisonline", "blood levels", "sterispharma", "Key Features", "T-lymphocytes", "Administration", "dosage regimen", "blood pressure", "immune response", "kidney problems", "transplant type", "white blood cell", "medical condition", "Immunosuppression", "therapeutic range", "regular monitoring", "healthcare provider", "Common side effects", "transplanted organs", "transplant medicine", "Serious side effects", "optimal effectiveness", "immediate medical attention", "potent immunosuppressive drug" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1493, "imageuri": "https://productimages.withfloats.com/actual/6662abb4bf1607f5c5cd3450.png", "tileimageuri": "https://productimages.withfloats.com/tile/6662abb4bf1607f5c5cd3450.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T06:41:53.713Z", "updatedon": "2026-03-13T05:56:29.586Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tacrenolime-0-25/1493", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TACRENOLIME 0.25", "category": "NEPHROLOGYRANGE", "tags": [ "TACRENOLIME 0.25", "Tacrolimus (0.25mg)", "tacrolimus capsule 0.25mg", "tacrolimus benefits", "tacrolimus level when to take", "tacrolimus benefits" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6662a7d22bed1f08484d685b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TACRENOLIME 1", "description": "TACRENOLIME 1\nTacrolimus Capsules (1mg)\nTacrenolime 1 is a medication available in capsule form, containing Tacrolimus in a 1mg strength. Tacrolimus is an immunosuppressant drug used to prevent rejection in organ transplant recipients. It works by suppressing the immune system's response to foreign substances, reducing the risk of the body rejecting transplanted organs such as the kidney, liver, or heart.\n\nThis medication is typically prescribed by healthcare professionals experienced in immunosuppressive therapy. Patients taking Tacrenolime 1 should follow their doctor's instructions carefully regarding dosage and administration. It is essential to take the medication at the same time each day to maintain consistent blood levels.\n\nTacrenolime 1 capsules should be swallowed whole with a glass of water, preferably on an empty stomach or as directed by a healthcare provider. It is crucial not to crush, chew, or break the capsules before swallowing, as this may alter the drug's effectiveness or cause adverse effects.\n\nCommon side effects of Tacrenolime 1 may include nausea, vomiting, diarrhea, headache, or changes in kidney function. Patients should report any severe or persistent side effects to their doctor promptly.\n\nIt is essential for patients taking Tacrenolime 1 to attend regular check-ups and blood tests as recommended by their healthcare provider to monitor their response to the medication and detect any potential complications early.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \n\nhttps://www.sterisonline.com/product/tacrenolime-1-133686\n\n\n\n\n\n\n", "price": 397.0, "discountamount": 120.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "risk", "body", "Order", "Email", "water", "glass", "heart", "liver", "severe", "nausea", "dosage", "doctor", "organs", "changes", "product", "response", "WhatsApp", "Patients", "diarrhea", "vomiting", "headache", "rejection", "same time", "medication", "information", "blood tests", "instructions", "sterisonline", "1mg strength", "sterispharma", "capsule form", "immune system", "empty stomach", "effectiveness", "administration", "kidney function", "adverse effects", "regular check-ups", "foreign substances", "Tacrolimus Capsules", "Common side effects", "healthcare provider", "Tacrenolime 1 capsules", "immunosuppressant drug", "consistent blood levels", "persistent side effects", "potential complications", "healthcare professionals", "immunosuppressive therapy", "organ transplant recipients" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1490, "imageuri": "https://productimages.withfloats.com/actual/6662a7d5d878d473a9fd83bb.png", "tileimageuri": "https://productimages.withfloats.com/tile/6662a7d5d878d473a9fd83bb.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T06:25:22.957Z", "updatedon": "2026-03-17T07:31:52.912Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tacrenolime-1/1490", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TACRENOLIME 1", "category": "NEPHROLOGYRANGE", "tags": [ "TACRENOLIME 1", "Tacrolimus Capsules (1mg)", "Tacrolimus 1 mg Tablet price", "Tacrolimus 1mg price in India", "Tacrolimus tablet uses", "Tacrolimus 1 Mg Capsule Uses in Hindi", "Tacrolimus Tablet side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6661a57d8da3a81d5c6a17dd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Mycophenolate mofetil 500mg", "description": "MYCOPLASM M 500\nMycophenolate mofetil (500mg)\nMycoplasm M 500 is a medication containing Mycophenolate Mofetil in a 500mg dose. Mycophenolate Mofetil is an immunosuppressive drug used to prevent rejection in organ transplantation, particularly kidney, heart, and liver transplants. It works by inhibiting the proliferation of T and B lymphocytes, which are involved in the immune response that leads to rejection.\n\nThis medication is typically prescribed in combination with other immunosuppressants as part of a comprehensive transplant treatment regimen. It is important to take Mycoplasm M 500 exactly as prescribed by your healthcare provider to ensure optimal therapeutic outcomes and to minimize the risk of rejection or other complications.\n\nCommon side effects of Mycophenolate Mofetil may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain. It can also increase the risk of infections due to its immunosuppressive effects. Patients should be monitored regularly by their healthcare provider while taking this medication to assess for any potential adverse effects and to adjust the dosage as needed.\n\nMycoplasm M 500 should not be used in pregnant women or those planning to become pregnant without consulting a healthcare professional, as it can cause harm to the developing fetus. Additionally, it may interact with other medications, so it is important to inform your doctor about all the medications you are currently taking before starting Mycoplasm M 500 therapy.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \n\n\n\n\nMycophenolate mofetil 500 mg stands as a cornerstone in modern immunosuppressive therapy, primarily designed to prevent organ transplant rejection in kidney, heart, and liver recipients. As a prodrug, it rapidly converts to its active form, mycophenolic acid (MPA), which selectively targets the proliferation of T and B lymphocytes—key players in immune responses that can attack transplanted organs. This medication, available in convenient 500 mg tablets, offers reliable protection against acute rejection episodes, making it an essential component in post-transplant regimens worldwide.​\n\nProduct Uses\nMycophenolate mofetil 500 mg finds its primary application in solid organ transplantation, where it helps maintain long-term graft survival. For kidney transplant patients, it is typically administered alongside corticosteroids and calcineurin inhibitors like cyclosporine or tacrolimus to suppress the immune system's overreaction to the new organ. In heart and liver transplants, it plays a similar role, reducing the incidence of rejection by inhibiting antibody production and cell-mediated immunity.​\n\nBeyond transplants, healthcare providers increasingly use mycophenolate mofetil 500 mg for various autoimmune conditions. It effectively manages lupus nephritis by curbing inflammation in the kidneys, showing superior efficacy over traditional therapies in preserving renal function. Rheumatoid arthritis patients benefit from its ability to dampen joint inflammation, while those with dermatomyositis or scleroderma experience reduced skin and muscle involvement. Off-label, it treats inflammatory bowel diseases like Crohn's disease and even certain skin disorders such as pemphigus vulgaris, where immune-mediated blistering threatens quality of life.​\n\nKey Benefits\nThe therapeutic advantages of mycophenolate mofetil 500 mg extend far beyond basic immunosuppression, offering patients enhanced outcomes and improved daily living.\n\nSuperior Graft Protection: Clinical data highlight reduced acute rejection rates by up to 50% when combined with standard regimens, leading to better long-term organ function and survival.​\n\nSelective Lymphocyte Targeting: By depleting guanosine nucleotides in T and B cells via inosine monophosphate dehydrogenase (IMPDH) inhibition, it spares other cell types, minimizing broad toxicity seen with older immunosuppressants.​\n\nAnti-Inflammatory Effects: MPA inhibits adhesion molecule glycosylation, preventing lymphocyte recruitment to inflamed sites, which alleviates symptoms in autoimmune flares.​\n\nOral Convenience: The 500 mg formulation allows flexible dosing—typically 1 gram twice daily—without the need for injections, improving patient adherence.​\n\nVersatility Across Conditions: Proven efficacy in lupus, vasculitis, and myositis expands its utility, often allowing steroid dose reduction and fewer relapses.​\n\nCardiovascular and Anticancer Potential: Emerging evidence suggests it delays graft atherosclerosis by reducing lipid oxidation and may hinder tumor progression in certain malignancies due to its impact on nucleotide synthesis.​\n\nThese benefits translate to fewer hospital readmissions, better quality of life, and cost savings in long-term care for transplant and autoimmune patients.​\n\nSide Effects\nWhile mycophenolate mofetil 500 mg provides robust immunosuppression, it carries risks typical of this drug class, necessitating vigilant monitoring.\n\nCommon side effects affect the gastrointestinal tract most prominently, with nausea, vomiting, diarrhea, and abdominal pain occurring in over 30% of users. These often improve with dose adjustments or enteric-coated alternatives, but hydration and antiemetics help manage them effectively.​\n\nHematologic issues like leukopenia, anemia, and thrombocytopenia arise due to bone marrow suppression, requiring regular complete blood counts—weekly initially, then monthly. Infections pose a significant threat, as suppressed immunity increases susceptibility to viral (e.g., CMV), bacterial, and fungal pathogens; prophylactic antivirals are standard.​\n\nLess frequent but notable effects include hypertension, tremor, insomnia, and elevated liver enzymes. Women face heightened risks of congenital malformations if used during pregnancy, mandating effective contraception and pregnancy testing. Rare severe reactions encompass progressive multifocal leukoencephalopathy (PML) from JC virus reactivation and hypersensitivity syndromes.​\n\nDosage and Administration Notes\nStandard dosing for renal transplants involves 1 gram (two 500 mg tablets) twice daily, starting within 72 hours post-surgery, with adjustments for renal impairment. Hepatic transplant patients may require higher initial doses due to metabolism differences. Always take on an empty stomach with water to optimize absorption, avoiding antacids that bind MPA.​\n\nPrecautions and Interactions\nPatients must avoid live vaccines, report fevers promptly, and undergo TB screening pre-treatment. Drug interactions with azathioprine, cholestyramine, or rifampin can alter levels, so pharmacists review regimens closely. Regular monitoring of MPA blood levels ensures therapeutic efficacy without toxicity.​\n\nConclusion\nMycophenolate mofetil 500 mg emerges as a transformative immunosuppressive agent, safeguarding transplanted organs and taming autoimmune storms with its precise mechanism of lymphocyte suppression and anti-inflammatory prowess. By delivering key benefits like reduced rejection, versatile applications, and manageable administration, it empowers patients to reclaim normalcy post-transplant or amid chronic illness. Despite potential side effects, proactive monitoring and personalized dosing mitigate risks, underscoring its value in contemporary medicine. For those navigating transplant recovery or autoimmune challenges, this medication offers hope and stability, backed by decades of clinical validation.\n\n", "price": 775.0, "discountamount": 256.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "part", "Call", "harm", "risk", "Email", "heart", "ORDER", "nausea", "kidney", "dosage", "doctor", "vomiting", "WhatsApp", "Patients", "diarrhea", "rejection", "infections", "500mg dose", "combination", "information", "sterisonline", "proliferation", "B lymphocytes", "abdominal pain", "pregnant women", "immune response", "developing fetus", "other medications", "liver transplants", "other complications", "healthcare provider", "Common side effects", "organ transplantation", "Mycophenolate mofetil", "immunosuppressive drug", "Mycoplasm M 500 therapy", "healthcare professional", "other immunosuppressants", "immunosuppressive effects", "potential adverse effects", "optimal therapeutic outcomes", "gastrointestinal disturbances", "comprehensive transplant treatment regimen" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1472, "imageuri": "https://productimages.withfloats.com/actual/6661a57fdd39d2ccddbc3bb9.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6661a57fdd39d2ccddbc3bb9.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:03:09.216Z", "updatedon": "2026-03-12T08:00:39.14Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/mycophenolate-mofetil-500mg/1472", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MYCOPLASM M 500", "category": "NEPHROLOGYRANGE", "tags": [ "MYCOPLASM M 500", "Mycophenolate mofetil (500mg)", "Mycophenolate mofetil 500 mg tablet", "Mycophenolate mofetil 500 mg price", "Mycophenolate mofetil 500 mg dosage", "Mycophenolate mofetil uses", "Mycophenolate mofetil side effects", "mycophenolate mofetil 500mg tablet uses", "mycophenolate mofetil 500mg dosage for kidney transplant", "mycophenolate mofetil 500mg for autoimmune disease" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6635ed538e18ce14f428c0c1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Tofacitinib 11 mg", "description": "TACOTINIB ER 11 \nTACOTINIB ER 11 (Tofacitinib 11 mg Extended Release) – Comprehensive Product Overview\n\nTACOTINIB ER 11 contains Tofacitinib 11 mg in an extended-release formulation designed for convenient once-daily dosing. Tofacitinib belongs to a class of medicines known as Janus kinase (JAK) inhibitors. It works by modulating the immune system to reduce inflammation and control symptoms in certain autoimmune conditions. TACOTINIB ER 11 is prescribed under medical supervision to help patients manage chronic inflammatory diseases effectively and improve quality of life.\n\nWhat is Tofacitinib 11 mg?\n\nTofacitinib is an oral targeted synthetic disease-modifying anti-rheumatic drug (tsDMARD). Unlike traditional immunosuppressive therapies, it specifically blocks JAK enzymes involved in the inflammatory signaling pathway. By inhibiting these pathways, TACOTINIB ER 11 reduces the overactive immune response responsible for joint damage, swelling, pain, and other systemic symptoms.\n\nThe extended-release (ER) 11 mg formulation ensures a steady release of medication over 24 hours, maintaining consistent blood levels while improving convenience compared to twice-daily immediate-release options.\n\nIndications and Uses of TACOTINIB ER 11\n\nTACOTINIB ER 11 is commonly prescribed for the management of:\n\n1. Rheumatoid Arthritis (RA)\n\nA chronic autoimmune condition that causes inflammation in the joints, leading to pain, stiffness, swelling, and progressive joint damage. Tofacitinib helps reduce inflammation and slow structural damage.\n\n2. Psoriatic Arthritis (PsA)\n\nAn inflammatory arthritis associated with psoriasis. TACOTINIB ER 11 helps manage joint symptoms and improves physical function.\n\n3. Ulcerative Colitis (UC)\n\nA chronic inflammatory bowel disease affecting the colon. Tofacitinib may help reduce intestinal inflammation and induce remission in moderate to severe cases.\n\n4. Ankylosing Spondylitis (AS) (as advised by a physician)\n\nMay be used in selected patients where other treatments are not effective.\n\nTreatment should always be initiated and monitored by a qualified healthcare professional.\n\nHow TACOTINIB ER 11 Works\n\nTACOTINIB ER 11 targets intracellular signaling pathways involved in immune cell activation. By blocking Janus kinase enzymes (JAK1 and JAK3 primarily), it prevents the transmission of pro-inflammatory cytokine signals. This results in:\n\nReduced joint inflammation\n\nDecreased immune overactivity\n\nRelief from pain and stiffness\n\nSlowing of disease progression\n\nBecause it acts on immune pathways, regular medical monitoring is required during treatment.\n\nKey Benefits of TACOTINIB ER 11\n✔ Effective Inflammation Control\n\nReduces swelling, pain, and tenderness in affected joints or tissues.\n\n✔ Improved Physical Function\n\nEnhances mobility and daily activity performance in patients with rheumatoid or psoriatic arthritis.\n\n✔ Convenient Once-Daily Dosing\n\nExtended-release 11 mg formulation improves patient compliance.\n\n✔ Targeted Mechanism of Action\n\nSpecifically inhibits JAK pathways, offering a modern therapeutic approach.\n\n✔ Reduced Disease Progression\n\nHelps prevent long-term structural joint damage when used appropriately.\n\n✔ Oral Administration\n\nUnlike some biologic therapies, TACOTINIB ER 11 is taken orally, eliminating the need for injections.\n\nDosage and Administration\n\nThe usual recommended dose is one tablet (11 mg) once daily, or as prescribed by your physician.\n\nTablets should be swallowed whole with water.\n\nDo not crush, chew, or split the tablet.\n\nCan be taken with or without food.\n\nDosage adjustments may be required in patients with liver impairment, kidney problems, or when used alongside certain medications.\n\nPossible Side Effects of TACOTINIB ER 11\n\nLike all medications, TACOTINIB ER 11 may cause side effects. Not everyone experiences them, but it is important to be aware of potential risks.\n\nCommon Side Effects:\n\nUpper respiratory tract infections\n\nHeadache\n\nDiarrhea\n\nNausea\n\nIncreased cholesterol levels\n\nMild increase in liver enzymes\n\nSerious Side Effects:\n\nSerious infections (tuberculosis, bacterial, viral, or fungal infections)\n\nBlood clots (deep vein thrombosis or pulmonary embolism)\n\nCardiovascular events in high-risk individuals\n\nReduced white blood cell count\n\nIncreased risk of certain cancers (with long-term use)\n\nSeek immediate medical attention if you experience:\n\nPersistent fever\n\nShortness of breath\n\nChest pain\n\nSevere abdominal pain\n\nUnusual bruising or bleeding\n\nRegular blood tests are required to monitor liver function, cholesterol levels, and blood cell counts during treatment.\n\nPrecautions and Warnings\n\nBefore starting TACOTINIB ER 11, inform your doctor if you:\n\nHave a history of recurrent infections\n\nHave liver or kidney disease\n\nHave tuberculosis or hepatitis\n\nAre pregnant or planning pregnancy\n\nAre breastfeeding\n\nHave a history of blood clots or cardiovascular disease\n\nVaccinations should be updated before initiating therapy. Live vaccines are generally not recommended during treatment.\n\nDrug Interactions\n\nTACOTINIB ER 11 may interact with:\n\nStrong CYP3A4 inhibitors (e.g., certain antifungals)\n\nImmunosuppressive drugs\n\nBiologic DMARDs\n\nCertain antibiotics\n\nAlways inform your healthcare provider about all medications and supplements you are taking.\n\nStorage Instructions\n\nStore below 25°C in a dry place\n\nProtect from moisture and direct sunlight\n\nKeep out of reach of children\n\nWho Should Avoid TACOTINIB ER 11?\n\nThis medication may not be suitable for:\n\nPatients with active serious infections\n\nIndividuals with severe liver impairment\nPatients at high risk of blood clots without proper medical supervision\nA detailed medical evaluation is necessary before starting therapy.\n\nConclusion\nTACOTINIB ER 11 (Tofacitinib 11 mg Extended Release) is an advanced oral treatment option for managing moderate to severe autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. By targeting JAK pathways, it effectively reduces inflammation, improves mobility, and enhances overall quality of life.\n", "price": 795.0, "discountamount": 239.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "class", "headache", "response", "guidance", "monitoring", "medication", "TACOTINIB ER", "inflammation", "Janus kinase", "immune system", "joint function", "JAK) inhibitors", "sustained relief", "prescribed dosage", "healthcare provider", "psoriatic arthritis", "Common side effects", "rheumatoid arthritis", "extended-release formulation", "Tofacitinib Extended Release", "gastrointestinal disturbances", "upper respiratory tract infections" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1102, "imageuri": "https://productimages.withfloats.com/actual/6635ed8ae837fe0918c055ff.png", "tileimageuri": "https://productimages.withfloats.com/tile/6635ed8ae837fe0918c055ff.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-05-04T08:09:55.768Z", "updatedon": "2026-03-14T06:26:01.73Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tofacitinib-11-mg/1102", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TACOTINIB ER 11", "category": "ORTHOLOGYRANG", "tags": [ "tofacitinib 11 mg", "tofacitinib 11 mg tablet", "tofacitinib 11 mg price", "tab tofacitinib 11 mg", "tofacitinib 11 mg uses", "Tofacitinib 11 mg extended release tablets", "Tofacitinib 11 mg ER for psoriatic arthritis treatment", "Tofacitinib 11 mg tablet uses and benefits", "Tofacitinib 11 mg ER dosage guide", "Tofacitinib 11 mg side effects and precautions", "Tofacitinib 11 mg daily autoimmune treatment" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }